Kee Diagnostics Private Limited, a active private limited company, was established on 16 August 2004 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U24231DL2004PTC128343. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.81 Cr.
Formerly known as Kee Gad Biogen Private Limited, Kee Biogenetics Private Limited. It upholds a compliant status. Employing 18 professional, Its leadership includes Samir Biswas (Managing Director), Anil Motihar (Director). Past directors included Samir Biswas, Rajeev Bahl, Harinder Motihar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A - 8, 3Rd Floor, Naraina Industrial Area, Phase-Ii,, New Delhi, Delhi, 110028.
U24231DL2004PTC128343
128343
16 August 2004
₹5.00 Cr
₹2.81 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Kee Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samir Biswas | Managing Director | 15 Apr 2018 | Current |
| Anil Motihar | Director | 16 Aug 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 04 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Alternate Director | 03 Dec 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 19 Jun 2018 | Past |
| Pramod Abcsdd | Managing Director | 31 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kee Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.87% increase. The company also saw a substantial improvement in profitability, with a 232.84% increase in profit. The company's net worth Soared by an impressive increase of 15.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kee Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Kee Diagnostics has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kee Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kee Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kee Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Kee Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Samir Biswas was appointed as a Managing Director was appointed as a Managing Director on 15 Apr 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
Anil Motihar was appointed as a Director was appointed as a Director on 16 Aug 2004 & has been associated with this company since 21 years 3 months . was recorded as a recent event.
Kee Diagnostics Private Limited was registered on 16 Aug 2004 with Roc Delhi & aged 21 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Kee Diagnostics Private Limited is U24231DL2004PTC128343.
Kee Diagnostics Private Limited is headquartered at A - 8, 3Rd Floor, Naraina Industrial Area, Phase-Ii,, New Delhi, Delhi, 110028.
Kee Diagnostics Private Limited was incorporated on 16 August 2004.
The current directors of Kee Diagnostics Private Limited are
The primary industry of Kee Diagnostics Private Limited is Manufacturing.
Kee Diagnostics Private Limited is unlisted.
The authorized capital of Kee Diagnostics Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.81 Cr.
The compliance status of Kee Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX